Provided are methods and compositions for the treatment or prevention of macular degeneration or other diseases or disorders associated with activation of TLR3. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity. As the approach phase starts, the method consists in determining a reduced voltage by decreasing the rotational speed of the motor from a nominal value to a predetermined reduced value and in cutting the motor power supply if the motor rotational speed drops below a predetermined threshold value. The main frame forms the support structure for the work table, the top of which is preferably covered by a 4 ft.